WELLBUTRIN SR
Dead / Cancelled — Cancelled — Section 8 (as of 12 Jan 2008)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75015631
- Registration number
- 2051603
- Mark type
- Design + words
- Filed
- 06 Nov 1995
- Published for opposition
- 23 Jul 1996
- Registered
- 08 Apr 1997
- Attorney of record
- MAURY M. TEPPER
Goods and services
- Class 005 — Pharmaceuticals: psychotropic preparations
Owner
- SMITHKLINE BEECHAM CORPORATION, PHILADELPHIA, PA, US
- BW USA, INC., RESEARCH TRIANGLE PARK, NC, US
- Glaxo Wellcome Inc., Research Triangle Park, NC, US
- Glaxo Wellcome Inc., Research Triangle Park, NC, US
- Glaxo Wellcome Inc., Research Triangle Park, NC, US
Prior registrations
Prosecution history
- 12 Jan 2008 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 14 Dec 2006 — CASE FILE IN TICRS
- 08 Jun 2006 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Jul 2003 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2003 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 08 Apr 2003 — TEAS SECTION 8 & 15 RECEIVED
- 08 Apr 1997 — REGISTERED-PRINCIPAL REGISTER
- 04 Feb 1997 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jan 1997 — ASSIGNED TO EXAMINER
- 15 Jan 1997 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jan 1997 — SOU EXTENSION 1 GRANTED
- 25 Nov 1996 — USE AMENDMENT FILED
- 25 Nov 1996 — SOU EXTENSION 1 FILED
- 15 Oct 1996 — NOA MAILED - SOU REQUIRED FROM APPLICANT
- 23 Jul 1996 — PUBLISHED FOR OPPOSITION